Cargando…

Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patients

Detalles Bibliográficos
Autores principales: Tan, Zheng, D’Costa, Ninadh M., Raven, Peter A., Chavez-Munoz, Claudia, So, Alan I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881214/
https://www.ncbi.nlm.nih.gov/pubmed/29644173
http://dx.doi.org/10.21037/tau.2017.12.17
_version_ 1783311276217204736
author Tan, Zheng
D’Costa, Ninadh M.
Raven, Peter A.
Chavez-Munoz, Claudia
So, Alan I.
author_facet Tan, Zheng
D’Costa, Ninadh M.
Raven, Peter A.
Chavez-Munoz, Claudia
So, Alan I.
author_sort Tan, Zheng
collection PubMed
description
format Online
Article
Text
id pubmed-5881214
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-58812142018-04-11 Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patients Tan, Zheng D’Costa, Ninadh M. Raven, Peter A. Chavez-Munoz, Claudia So, Alan I. Transl Androl Urol Editorial AME Publishing Company 2018-03 /pmc/articles/PMC5881214/ /pubmed/29644173 http://dx.doi.org/10.21037/tau.2017.12.17 Text en 2018 Translational Andrology and Urology. All rights reserved.
spellingShingle Editorial
Tan, Zheng
D’Costa, Ninadh M.
Raven, Peter A.
Chavez-Munoz, Claudia
So, Alan I.
Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patients
title Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patients
title_full Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patients
title_fullStr Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patients
title_full_unstemmed Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patients
title_short Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patients
title_sort identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patients
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881214/
https://www.ncbi.nlm.nih.gov/pubmed/29644173
http://dx.doi.org/10.21037/tau.2017.12.17
work_keys_str_mv AT tanzheng identificationofhypoxicgenesignatureasaprognosticandpredictivebiomarkertodetermineeffectivetherapyinhighriskbladdercancerpatients
AT dcostaninadhm identificationofhypoxicgenesignatureasaprognosticandpredictivebiomarkertodetermineeffectivetherapyinhighriskbladdercancerpatients
AT ravenpetera identificationofhypoxicgenesignatureasaprognosticandpredictivebiomarkertodetermineeffectivetherapyinhighriskbladdercancerpatients
AT chavezmunozclaudia identificationofhypoxicgenesignatureasaprognosticandpredictivebiomarkertodetermineeffectivetherapyinhighriskbladdercancerpatients
AT soalani identificationofhypoxicgenesignatureasaprognosticandpredictivebiomarkertodetermineeffectivetherapyinhighriskbladdercancerpatients